Mangrove Partners Corbus Pharmaceuticals Holdings, Inc. Call Options Transaction History

Mangrove Partners

  • $890 Million
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$0.94 - $1.89 $2.36 Million - $4.75 Million
-2,513,300 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$1.5 - $9.38 $2.94 Million - $18.4 Million
1,961,100 Added 355.14%
2,513,300 $4.52 Million
Q2 2020

Aug 14, 2020
BUY
$4.79 - $8.39 $2.2 Million - $3.86 Million
459,700 Added 496.97%
552,200 $4.63 Million
Q1 2020

May 15, 2020
BUY
$3.44 - $7.21 $318,200 - $666,925
92,500 New
92,500 $485,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $6.51B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Mangrove Partners Portfolio

Follow Mangrove Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

News

Stay updated on Mangrove Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email